CHIARINI, Francesca

CHIARINI, Francesca  

Dipartimento di Scienze Biomediche, Metaboliche e Neuroscienze  

Mostra records
Risultati 1 - 20 di 87 (tempo di esecuzione: 0.021 secondi).
Titolo Data di pubblicazione Autore(i) File
13. PLCβ1a and PLCβ1b selective regulation and cyclin D3 modulation reduced by kinamycin F during k562 cell differentiation 1-gen-2015 Bavelloni, A; Dmitrienko, Gi; Goodfellow, Vj; Ghavami, A; Piazzi, M; Blalock, W; Chiarini, F; Cocco, L; Faenza, I
A COMBINATION OF BORTEZOMIB WITH CX-4945, A CASEIN KINASE 2 (CK2) INHIBITOR, HAS SYNERGISTIC CYTOTOXIC EFFECTS IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) CELL LINES 1-gen-2014 Buontempo, Francesca; Orsini, E; Cappellini, Alessandra; Lonetti, Annalisa; Evangelisti, C; Chiarini, Francesca; Spartà, Am; Bressanin, D; Evangelisti, C; Martelli, Am
A combination of temsirolimus, an allosteric mTOR inhibitor, with clofarabine as a new therapeutic option for patients with acute myeloid leukemia 1-gen-2012 Chiarini, F; Lonetti, A; Teti, G; Orsini, E; Bressanin, D; Cappellini, A; Ricci, F; Tazzari, Pl; Ognibene, A; Falconi, M; Pagliaro, P; Iacobucci, I; Martinelli, G; Amadori, S; Mccubrey, Ja; Martelli, Am.
A role of PI-PLCb1 in G1/S transition in human erythroleukemia k562 cells 1-gen-2012 Poli, Alessandro; Faenza, Irene; Matteucci, Alessandro; Chiarini, Francesca; Cocco, LUCIO ILDEBRANDO
Activity of the pan-class I phosphoinositide 3-kinase inhibitor NVP-BKM120 in T-cell acute lymphoblastic leukemia 1-gen-2014 Lonetti, A; Antunes, Il; Chiarini, F; Orsini, E; Buontempo, F; Ricci, F; Tazzari, Pl; Pagliaro, P; Melchionda, F; Pession, A; Bertaina, A; Locatelli, F; Mccubrey, Ja; Barata, Jt; Martelli, Am.
Activity of the selective IκB kinase inhibitor BMS-345541 against T-cell acute lymphoblastic leukemia: involvement of FOXO3a 1-gen-2012 Buontempo, F; Chiarini, F; Bressanin, D; Tabellini, G; Melchionda, F; Pession, A; Fini, M; Neri, Lm; Mccubrey, Ja; Martelli, Am.
Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: From biology to therapeutic targeting 1-gen-2016 Chiarini, F; Lonetti, A; Evangelisti, C; Buontempo, F; Orsini, E; Evangelisti, C; Cappellini, A; Neri, Lm; Mccubrey, Ja; Martelli, Am
Advances in understanding the mechanisms of evasive and innate resistance to mTOR inhibition in cancer cells 1-gen-2019 Chiarini, F; Evangelisti, C; Lattanzi, G; Mccubrey, Ja; Martelli, Am.
Age-Related Alterations Affecting the Chondrogenic Differentiation of Synovial Fluid Mesenchymal Stromal Cells in an Equine Model 1-gen-2019 Mazzotti, E; Teti, G; Falconi, M; Chiarini, F; Barboni, B; Mazzotti, A; Muttini, A.
Alteration of Akt activity increases chemotherapeutic drug and hormonal resistance in breast cancer yet confers an achilles heel by sensitization to targeted therapy 1-gen-2008 Mccubrey, J. A.; Sokolosky, M. L.; Lehmann, B. D.; Taylor, J. R.; Navolanic, P. M.; Chappell, W. H.; Abrams, S. L.; Stadelman, K. M.; Wong, E. W.; Misaghian, N.; Horn, S.; Bäsecke, J.; Libra, M.; Stivala, F.; Ligresti, G.; Tafuri, A.; Milella, M.; Zarzycki, M.; Dzugaj, A.; Chiarini, Francesca; Evangelisti, Camilla; Martelli, ALBERTO MARIA; Terrian, D. M.; Franklin, R. A.; Steelman, L. S.
AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications 1-gen-2012 Grimaldi, Cecilia; Chiarini, Francesca; Tabellini, G.; Ricci, F.; Tazzari, P. L.; Battistelli, M.; Falcieri, E.; Bortul, R.; Melchionda, F.; Iacobucci, Ilaria; Pagliaro, P.; Martinelli, Giovanni; Pession, Andrea; Barata, J. T.; Mccubrey, J. A.; Martelli, ALBERTO MARIA
Antigene MYCN Silencing by BGA002 Inhibits SCLC Progression Blocking mTOR Pathway and Overcomes Multidrug Resistance 1-gen-2023 Bortolotti, S.; Angelucci, S.; Montemurro, L.; Bartolucci, D.; Raieli, S.; Lampis, S.; Amadesi, C.; Scardovi, A.; Nieddu, G.; Cerisoli, L.; Paganelli, F.; Chiarini, F.; Teti, G.; Falconi, M.; Pession, A.; Hrelia, P.; Tonelli, R.
ASSESSMENT OF THE EFFECT OF SPHINGOSINE KINASE INHIBITORS ON APOPTOSIS, UNFOLDED PROTEIN RESPONSE AND AUTOPHAGY OF T-ACUTE LYMPHOBLASTIC LEUKEMIA CELLS: INDICATIONS FOR NOVEL THERAPEUTICS 1-gen-2014 Evangelisti, Cecilia; Evangelisti, Camilla; Teti, Gabriella; Falconi, Mirella; Cappellini, Alessandra; Chiarini, Francesca; Buontempo, Francesca; Bressanin, D; Lonetti, Annalisa; Spartà, A; Bittman, R; Pyne, S; Pyne, N; Martelli, Am
Assessment of the effect of sphingosine kinase inhibitors on apoptosis,unfolded protein response and autophagy of T-cell acute lymphoblastic leukemia cells; indications for novel therapeutics 1-gen-2014 Evangelisti, C; Evangelisti, C; Teti, G; Chiarini, F; Falconi, M; Melchionda, F; Pession, A; Bertaina, A; Locatelli, F; Mccubrey, Ja; Beak, Dj; Bittman, R; Pyne, S; Pyne, Nj; Martelli, Am
Assessment of the structural and functional characteristics of human mesenchymal stem cells associated with a prolonged exposure of morphine 1-gen-2021 Carano, Francesco; Teti, Gabriella; Ruggeri, Alessandra; Chiarini, Francesca; Giorgetti, Arianna; Mazzotti, Maria C; Fais, Paolo; Falconi, Mirella
Autophagy in acute leukemias: a double-edged sword with important therapeutic implications 1-gen-2015 Evangelisti, C; Evangelisti, C; Chiarini, F; Lonetti, A; Buontempo, F; Neri, Lm; Mccubrey, Ja; Martelli, Am
B-ALL Complexity: Is Targeted Therapy Still A Valuable Approach for Pediatric Patients? 1-gen-2020 Ratti, S; Lonetti, A; Follo, My; Paganelli, F; Martelli, Am; Chiarini, F; Evangelisti, C
Cellular senescence in vascular wall mesenchymal stromal cells, a possible contribution to the development of aortic aneurysm 1-gen-2021 Teti, G; Chiarini, F; Mazzotti, E; Ruggeri, A; Carano, F; Falconi, M.
Crosstalks of GSK3 signaling with the mTOR network and effects on targeted therapy of cancer 1-gen-2020 Evangelisti, C; Chiarini, F; Paganelli, F; Marmiroli, S; Martelli, Am
Current treatment strategies for inhibiting mTOR in cancer 1-gen-2015 Chiarini, F; Evangelisti, C; Mccubrey, Ja; Martelli, Am